LLY

1,015.42

-0.45%↓

JNJ

243.44

-0.97%↓

ABBV

225.92

+0.78%↑

NVS

163.49

+0.13%↑

MRK

121.71

-0.06%↓

LLY

1,015.42

-0.45%↓

JNJ

243.44

-0.97%↓

ABBV

225.92

+0.78%↑

NVS

163.49

+0.13%↑

MRK

121.71

-0.06%↓

LLY

1,015.42

-0.45%↓

JNJ

243.44

-0.97%↓

ABBV

225.92

+0.78%↑

NVS

163.49

+0.13%↑

MRK

121.71

-0.06%↓

LLY

1,015.42

-0.45%↓

JNJ

243.44

-0.97%↓

ABBV

225.92

+0.78%↑

NVS

163.49

+0.13%↑

MRK

121.71

-0.06%↓

LLY

1,015.42

-0.45%↓

JNJ

243.44

-0.97%↓

ABBV

225.92

+0.78%↑

NVS

163.49

+0.13%↑

MRK

121.71

-0.06%↓

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Отворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	6.8M -8.1M
Продажби	33M 72M
Марж на печалбата	-11.242
Служители	105
EBITDA	6.7M -5.4M

Дивиденти
By Dow Jones
Следващи печалби	19.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	45M 136M
Предишно отваряне	0
Предишно затваряне	0

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

19.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19.02.2026 г., 23:39 ч. UTC

Придобивния, сливания и поглъщания

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19.02.2026 г., 23:38 ч. UTC

Печалби

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19.02.2026 г., 23:34 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19.02.2026 г., 23:34 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19.02.2026 г., 23:33 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19.02.2026 г., 23:33 ч. UTC

Печалби

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19.02.2026 г., 22:13 ч. UTC

Пазарно говорене

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19.02.2026 г., 22:08 ч. UTC

Печалби

Fairfax Financial 4Q Rev $8.11B >FFH.T

19.02.2026 г., 22:07 ч. UTC

Печалби

Eldorado Gold 4Q EPS $1.19 >ELD.T

19.02.2026 г., 22:06 ч. UTC

Печалби

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19.02.2026 г., 22:05 ч. UTC

Печалби

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19.02.2026 г., 22:05 ч. UTC

Печалби

Eldorado Gold 4Q Rev $577.2M >ELD.T

19.02.2026 г., 22:04 ч. UTC

Печалби

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19.02.2026 г., 22:04 ч. UTC

Печалби

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

19.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.02.2026 г., 21:43 ч. UTC

Печалби

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19.02.2026 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19.02.2026 г., 21:42 ч. UTC

Печалби

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19.02.2026 г., 21:41 ч. UTC

Печалби

Correct: St Barbara 1H Net Loss A$249,000

19.02.2026 г., 21:40 ч. UTC

Печалби

St Barbara 1H Net Loss A$249 Million

19.02.2026 г., 21:39 ч. UTC

Печалби

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19.02.2026 г., 21:37 ч. UTC

Печалби

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19.02.2026 г., 21:37 ч. UTC

Печалби

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.